About Aroa Biosurgery
Aroa Biosurgery is a company based in Mangere (New Zealand) founded in 2008. Aroa Biosurgery operates in a competitive market with competitors including Humacyte, Kerecis, Miach Orthopaedics, CUTISS and Rotation Medical, among others.
- Headquarter Mangere, New Zealand
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aroa Biosurgery Limited
-
Annual Revenue
$48.15 M (USD)20.43as on Mar 31, 2025
-
Net Profit
-$2.17 M (USD)64.77as on Mar 31, 2025
-
EBITDA
$535.5 K (USD)0as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Aroa Biosurgery
Aroa Biosurgery is a publicly listed company on the ASX with ticker symbol ARX in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Aroa Biosurgery
Detailed funding history for Aroa Biosurgery
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aroa Biosurgery
Investment portfolio details for Aroa Biosurgery
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aroa Biosurgery
Detailed financials for Aroa Biosurgery
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aroa Biosurgery Comparisons
Peer comparison for Aroa Biosurgery
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aroa Biosurgery
Aroa Biosurgery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Humacyte, Kerecis, Miach Orthopaedics, CUTISS and Rotation Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Human tissue-based products are developed for vascular disease applications.
|
|
| Locked | Locked | Locked |
Fish-skin acellular dermal matrix technology is provided for wound treatments.
|
|
| Locked | Locked | Locked |
Bio-engineered surgical implants for connective tissue repair are developed.
|
|
| Locked | Locked | Locked |
Personalized skin tissue therapy is developed by CUTISS for surgeries.
|
|
| Locked | Locked | Locked |
A rotator cuff repair system is developed for disease treatment.
|
|
| Locked | Locked | Locked |
Soft tissue reconstruction solutions for knee and shoulder
|
Detailed competitors of Aroa Biosurgery
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aroa Biosurgery
Complete news archive for Aroa Biosurgery
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aroa Biosurgery
Aroa Biosurgery was founded in 2008.
Aroa Biosurgery is headquartered in Mangere, New Zealand.
Annual revenue of Aroa Biosurgery is $48.15M as on Mar 31, 2025.
Aroa Biosurgery was founded in 2008 in Mangere, New Zealand, and operates in the medical and surgical sector. Proprietary AROA ECM technology is utilized to create extracellular matrix biomaterials derived from ovine forestomach. These materials support wound healing and soft tissue reconstruction. Key products include Endoform, Myriad Matrix, Myriad Morcells, and Reinforced Bioscaffold, which are applied in clinical settings for tissue repair.
Yes, Aroa Biosurgery is publicly traded on ASX under the ticker symbol ARX.
The ticker symbol of Aroa Biosurgery is ARX on ASX.